PSORIASIS 16
References
Aghmiuni, A. I., & Khiavi, A. A. (2017). Medicinal Plants to Calm and Treat Psoriasis Disease.
In Aromatic and Medicinal Plants-Back to Nature. InTech.
Boutet, M. A., Nerviani, A., Gallo Afflitto, G., & Pitzalis, C. (2018). Role of the IL-23/IL-17 axis
in psoriasis and psoriatic arthritis: The clinical importance of its divergence in skin and
joints. International journal of molecular sciences, 19(2), 530.
Gulliver, W. (2018). Long‐term prognosis in patients with psoriasis. British Journal of
Dermatology, 159(s2), 2-9.
Irimie, M., Oanta, A., Alexandrina Irimie, C., Gyula Fekete, L., Ioan Minea, D., & Pascu, A.
(2015). Cardiovascular risk factors in patients with chronic plaque psoriasis: a case-control
study on the Brasov County population. Acta Dermatovenerologica Croatica, 23(1), 28-
28.
Kimball, A. B., Leonardi, C., Stahle, M., Gulliver, W., Chevrier, M., Fakharzadeh, S., ... &
PSOLAR Steering Committee. (2014). Demography, baseline disease characteristics and
treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐
based registry (PSOLAR). British Journal of Dermatology, 171(1), 137-147.
Sarac, G., Koca, T. T., & Baglan, T. (2016). A brief summary of clinical types of
psoriasis. Northern clinics of Istanbul, 3(1), 79.
US Food and Drug Administration. (2013). The voice of the patient. A series of reports from the
US Food and Drug Administration’s (FDA’s) patient-focused drug development initiative.
Chronic fatigue syndrome and myalgic encephalomyelitis.
World Health Organization. (2016). Global report on psoriasis. 2016. WHO Library Cataloguing-
in-Publication Data.